PTK2 and breast carcinoma: PYK2 is also aberrantly expressed in breast cancer and several studies have shown that, similar to FAK, aberrant expression of PYK2 promotes breast cancer cell proliferation, migration, invasion, metastasis, and chemo-resistance [43].